Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Angiodynamics Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
ANGO · Nasdaq · Healthcare · Medical Instruments and Supplies
$11.98-3.5%Nov 12 close
Figures through August 31, 2026, from the 10-Q filed October 8, 2026
Company outlook: revenue of $336M to $341M for Fiscal year 2027 — up 5.7% on a year earlier